Literature DB >> 11018668

Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium.

A L Bailey1, S M Sullivan.   

Abstract

Efficient encapsulation of DNA plasmids inside small, neutral liposomes composed of 1,2-dioleoyl-sn-phosphatidylcholine (DOPC), DOPC/DOPE (1,2-dioleoyl-sn-phosphatidylethanolamine) (1:1) and DOPC/DOPE/cholesterol (1:1:1) was achieved by the addition of ethanol and calcium chloride to an aqueous mixture of small unilamellar vesicles (SUVs) and plasmid. Following dialysis against low-salt buffer, the neutral lipid complexes (NLCs) had average effective diameters less than 200 nm and encapsulated up to 80% of the DNA. Optimum Ca(2+) and ethanol concentrations for each lipid mixture were determined by statistically designed experiments and mathematical modeling of trapping efficiency. NLCs are unilamellar, have neutral surface potentials, and retain entrapped DNA at pH 4.0 and in serum at 37 degrees C. The circulation and clearance properties of the complexes following intravenous administration in mice are similar to empty neutral liposomes, and the toxicity of NLCs are expected to be significantly reduced compared to other non-viral gene-delivery systems. The NLC encapsulation method, if it can be combined with effective targeting and endosome-release technologies to achieve efficient and tissue-specific transfection, may represent an important alternative to current systemic gene therapy approaches.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018668     DOI: 10.1016/s0005-2736(00)00264-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Transfection efficiency of pORF lacZ plasmid lipopolyplex to hepatocytes and hepatoma cells.

Authors:  Xun Sun; Hong-Wei Zhang; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

2.  Surfactant assemblies and their various possible roles for the origin(s) of life.

Authors:  Peter Walde
Journal:  Orig Life Evol Biosph       Date:  2006-04-27       Impact factor: 1.950

Review 3.  Lipid-based nanoparticles for nucleic acid delivery.

Authors:  Weijun Li; Francis C Szoka
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

5.  A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA.

Authors:  Lloyd B Jeffs; Lorne R Palmer; Ellen G Ambegia; Cory Giesbrecht; Shannon Ewanick; Ian MacLachlan
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen.

Authors:  Vincent W Bramwell; Jim E Eyles; Satyanarayana Somavarapu; H Oya Alpar
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

7.  Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system.

Authors:  Junkun He; David L Evers; Timothy J O'Leary; Jeffrey T Mason
Journal:  J Nanobiotechnology       Date:  2012-06-22       Impact factor: 10.435

8.  Characterizing DNA condensation and conformational changes in organic solvents.

Authors:  Fuyou Ke; Yen Kim Luu; Michael Hadjiargyrou; Dehai Liang
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

9.  Novel liposomal formulation for targeted gene delivery.

Authors:  Véronique Rivest; Alix Phivilay; Carl Julien; Sandra Bélanger; Cyntia Tremblay; Vincent Emond; Frédéric Calon
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.580

10.  Synergistic Immunostimulation through the Dual Activation of Toll-like Receptor 3/9 with Spherical Nucleic Acids.

Authors:  Ziyin N Huang; Cassandra E Callmann; Lisa E Cole; Shuya Wang; Chad A Mirkin
Journal:  ACS Nano       Date:  2021-07-19       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.